COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 159 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $576,228 | +4.0% | 25,782 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $554,056 | +5.6% | 25,782 | +17.9% | 0.00% | 0.0% |
| Q1 2023 | $524,661 | +67164.2% | 21,870 | -34.9% | 0.00% | -50.0% |
| Q4 2022 | $780 | +44.7% | 33,597 | 0.0% | 0.00% | +33.3% |
| Q3 2022 | $539 | -99.9% | 33,597 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $584,000 | +117.1% | 32,964 | +149.8% | 0.00% | +200.0% |
| Q1 2022 | $269,000 | -39.8% | 13,195 | -44.9% | 0.00% | -50.0% |
| Q4 2021 | $447,000 | -5.5% | 23,940 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $473,000 | -20.4% | 23,940 | -4.7% | 0.00% | 0.0% |
| Q2 2021 | $594,000 | +102.0% | 25,133 | +102.9% | 0.00% | +100.0% |
| Q1 2021 | $294,000 | +149.2% | 12,388 | +20.4% | 0.00% | 0.0% |
| Q3 2019 | $118,000 | -36.6% | 10,288 | -27.2% | 0.00% | 0.0% |
| Q2 2019 | $186,000 | +31.9% | 14,129 | +52.0% | 0.00% | 0.0% |
| Q1 2019 | $141,000 | – | 9,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |